EUCROF27

Peter Casteleyn, MSc, is a Technology Director whose mantra is enabling business to work smarter. With a career of over 24 years in the pharmaceutical industry, Peter has made significant contributions across various domains, including Commercial, Supply Chain, Development and Analytics. His work places him at the forefront of technological innovation in the field as he contributed to and triggered cross-industry collaborations in the area of bridging clinical care with clinical research.

End 2024, Peter retired from Johnson & Johnson after the successful introduction of a scalable Electronic Health Records integration capability.  Since then, he joined the European Institute for Innovation through Health Data (I~HD) as clinical data strategy advisor, co-leading initiatives as the eSource scale-up Taskforce and parts of European Commission funded initiatives bridging clinical care and clinical research. He firmly believes in the importance of insights from data for the health care industry supported by the interoperability of health data and that industry wide collaboration is the key to achieve this. 

Marcello Milano is a director in the R&D and Regulatory Policy team at BioMarin, a global biotechnology company that develops innovative therapies for rare genetic diseases. In his role, Marcello focuses on EU regulatory intelligence, regulatory policy development and advocacy as a member of working groups across industry organizations, including EuropaBio, EUCOPE, ARM, MPP and BIA. Amongst other roles, he acts as EUCOPE alternate in the Accelerating Clinical Trials in Europe (ACT-EU) Multistakeholder Platform Advisory Group.

Marcello has been part of the biopharmaceutical industry for about 30 years, of which nearly 20 in the regulatory affairs field, with previous roles in Chiesi and GSK. He holds a chemistry degree from the University of Padua, Italy.